Yuanhong Ge, Qingjia Lai, Yunsen Zhang, Yao Wang, Xuejun Xu
{"title":"Oculomotor Nerve Palsy Secondary to Posterior Communicating Artery Aneurysm: A Narrative Review and Proposed Treatment Algorithm.","authors":"Yuanhong Ge, Qingjia Lai, Yunsen Zhang, Yao Wang, Xuejun Xu","doi":"10.31083/RN40930","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Oculomotor nerve palsy (ONP) is a condition characterized by ptosis, restricted eye movement, and pupillary abnormalities, with causes ranging from congenital to acquired factors. Among these, posterior communicating artery aneurysm (PcomA) represents the most clinically urgent due to the risk of rupture. Despite its significance, no standardized treatment guidelines currently exist. This narrative review aims to summarize current treatment approaches and provide a decision-making framework for clinicians.</p><p><strong>Methods: </strong>A literature review was conducted using Web of Science and PubMed from inception to December 30, 2024, with additional sources identified via manual reference searches.</p><p><strong>Results: </strong>Both aneurysm clipping and endovascular therapy are effective for treating PcomA-induced ONP. Endovascular techniques include coil embolization, stent- or balloon-assisted coiling, flow diverter placement, and intrasaccular flow disruption device placement. Surgical clipping is preferred in younger patients (under 60 years old), those with ONP symptoms longer than 7 days, an aneurysm size ≥7 mm, or complete ONP. In contrast, endovascular therapy is recommended for older patients, those in poor health, or undergoing treatment with antithrombotic agents. Emerging evidence suggests flow diverter placement is a promising direction, though further research is warranted.</p><p><strong>Conclusion: </strong>This review proposes a therapeutic algorithm to aid in clinical decision-making. The choice between aneurysm clipping and endovascular therapy should be individualized, taking into account patient-specific clinical factors.</p>","PeriodicalId":21281,"journal":{"name":"Revista de neurologia","volume":"80 10","pages":"40930"},"PeriodicalIF":0.6000,"publicationDate":"2025-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12681010/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista de neurologia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.31083/RN40930","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Oculomotor nerve palsy (ONP) is a condition characterized by ptosis, restricted eye movement, and pupillary abnormalities, with causes ranging from congenital to acquired factors. Among these, posterior communicating artery aneurysm (PcomA) represents the most clinically urgent due to the risk of rupture. Despite its significance, no standardized treatment guidelines currently exist. This narrative review aims to summarize current treatment approaches and provide a decision-making framework for clinicians.
Methods: A literature review was conducted using Web of Science and PubMed from inception to December 30, 2024, with additional sources identified via manual reference searches.
Results: Both aneurysm clipping and endovascular therapy are effective for treating PcomA-induced ONP. Endovascular techniques include coil embolization, stent- or balloon-assisted coiling, flow diverter placement, and intrasaccular flow disruption device placement. Surgical clipping is preferred in younger patients (under 60 years old), those with ONP symptoms longer than 7 days, an aneurysm size ≥7 mm, or complete ONP. In contrast, endovascular therapy is recommended for older patients, those in poor health, or undergoing treatment with antithrombotic agents. Emerging evidence suggests flow diverter placement is a promising direction, though further research is warranted.
Conclusion: This review proposes a therapeutic algorithm to aid in clinical decision-making. The choice between aneurysm clipping and endovascular therapy should be individualized, taking into account patient-specific clinical factors.
背景:动眼神经麻痹(ONP)是一种以上睑下垂、眼球运动受限和瞳孔异常为特征的疾病,其病因从先天性到后天因素不等。其中,后交通动脉瘤(PcomA)由于有破裂的危险,在临床上最为急迫。尽管其意义重大,但目前尚无标准化的治疗指南。本综述旨在总结当前的治疗方法,并为临床医生提供决策框架。方法:使用Web of Science和PubMed从建站到2024年12月30日进行文献综述,并通过手动参考检索确定其他来源。结果:动脉瘤夹闭和血管内治疗均能有效治疗pcoma所致的ONP。血管内技术包括线圈栓塞、支架或球囊辅助盘绕、血流分流器放置和囊内血流阻断装置放置。年轻患者(60岁以下)、ONP症状持续时间超过7天、动脉瘤大小≥7mm或完全ONP的患者首选手术切除。相反,血管内治疗推荐用于老年患者、健康状况不佳的患者或正在接受抗血栓药物治疗的患者。新出现的证据表明,分流器的安置是一个有希望的方向,尽管进一步的研究是必要的。结论:本综述提出了一种辅助临床决策的治疗算法。动脉瘤夹闭和血管内治疗之间的选择应个体化,考虑到患者特定的临床因素。